2026 data FDA MAUDE openFDA FDA Class III

Implantable Cardioverter Defibrillator (Non-Crt)

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Implantable Cardioverter Defibrillator HEAVY-BOOK · MAUDE

#10 of 1000 · 379,353 reports · 1992–2026

  • BOOK 379,353 reports
  • RANK #10 of 1000
  • DEATH 10,094 death-typed
  • INJ 226,424 injury-typed
  • MALF 141,519 malfunction
  • SPAN 1992–2026
  • PEAK 2023: 28,702
  • PHOTO Stimulator

Nearest event-volume peer: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (3,643 report gap)

Implantable Cardioverter Defibrillator (Non-Crt) sits #10 of 1000 among tracked device types with 379,353 MAUDE reports spanning 1992–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Injury-coded reports run above the device-type norm

Implantable Cardioverter Defibrillator carries 59.7% INJURY-coded reports, 29.4pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 2.7% corpus 1.5% · above corpus mean (+1.2 pp)
  • INJ 59.7% corpus 30.3% · above corpus mean (+29.4 pp)
  • MALF 37.3% corpus 64.8% · below corpus mean (-27.5 pp)

Lead product-problem code Over-Sensing is 18% of coded problems · Lead manufacturer BOSTON SCIENTIFIC CORPORATION accounts for 26% of manufacturer-tagged reports · Top event location is 44% of location-tagged rows .

Implantable Cardioverter Defibrillator in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Implantable Cardioverter Defibrillator (Non-Crt) carries 379,353 MAUDE reports, ranked #10 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Injury 226,424 (59.7%)
Malfunction 141,519 (37.3%)
Death 10,094 (2.7%)
671 (0.2%)
Other 644 (0.2%)
No answer provided 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Hospitalization 111,515 (20.6%)
109,199 (20.2%)
R 106,146 (19.6%)
Required Intervention 86,722 (16.0%)
Other 43,233 (8.0%)
L 31,303 (5.8%)
H 25,455 (4.7%)
Life Threatening 13,732 (2.5%)
Death 9,883 (1.8%)
O 3,196 (0.6%)
S 216 (0.0%)
D 148 (0.0%)
Disability 64 (0.0%)
Congenital Anomaly 30 (0.0%)
Invalid Data 9 (0.0%)
C 1 (0.0%)

Top Product Problems

Over-Sensing 79,972
High impedance 59,335
Inappropriate/Inadequate Shock/Stimulation 48,505
Adverse Event Without Identified Device or Use Problem 44,468
Premature Discharge of Battery 30,831
Signal Artifact/Noise 30,012
Fracture 22,053
Impedance Problem 16,636
Device Sensing Problem 14,640
Pacing Problem 14,317
High Capture Threshold 13,603
Under-Sensing 11,681
Low impedance 10,731
Failure to Capture 9,932
Low Battery 9,599
Incorrect, Inadequate or Imprecise Result or Readings 8,750
Appropriate Device Problem Term/Code Not Available 7,982
Failure to Read Input Signal 7,914
Battery Problem 7,751
Normal 7,046

Yearly Trend

92
1992: 20
93
1993: 9
94
1994: 59
95
1995: 135
96
1996: 274
97
1997: 2,867
98
1998: 1,867
99
1999: 1,224
00
2000: 2,057
01
2001: 2,247
02
2002: 2,393
03
2003: 2,713
04
2004: 2,761
05
2005: 2,903
06
2006: 6,279
07
2007: 10,328
08
2008: 11,331
09
2009: 13,768
10
2010: 17,322
11
2011: 15,097
12
2012: 12,823
13
2013: 17,242
14
2014: 18,593
15
2015: 14,040
16
2016: 16,638
17
2017: 18,454
18
2018: 17,228
19
2019: 16,183
20
2020: 16,907
21
2021: 19,653
22
2022: 23,453
23
2023: 28,702
24
2024: 25,202
25
2025: 24,630
26
2026: 13,951

Reports in 2025 (24,630) held close to the prior two-year average of 26,952.

Related Entities for Implantable Cardioverter Defibrillator (Non-Crt)

Event Locations

165,570 (43.6%)
I 109,574 (28.9%)
HOSPITAL 83,759 (22.1%)
OTHER 10,489 (2.8%)
OUTPATIENT TREATMENT FACILITY 6,645 (1.8%)
HOME 1,070 (0.3%)
CLINIC - WALK IN, OTHER 567 (0.1%)
NO INFORMATION 440 (0.1%)
NOT APPLICABLE 422 (0.1%)
UNKNOWN 346 (0.1%)
INVALID DATA 266 (0.1%)
PATIENT'S HOME 98 (0.0%)
OUTPATIENT DIAGNOSTIC FACILITY 54 (0.0%)
AMBULATORY SURGICAL FACILITY 20 (0.0%)
EMERGENCY ROOM 6 (0.0%)
NURSING HOME 6 (0.0%)
EXAMINATION ROOM 5 (0.0%)
OPERATING ROOM 3 (0.0%)
OUTDOORS 3 (0.0%)
PUBLIC VENUE 3 (0.0%)
HOSPICE 2 (0.0%)
OUTPATIENT CLINIC/SURGERY 1 (0.0%)
P 1 (0.0%)
PUBLIC BUILDING 1 (0.0%)
REHABILITATION CENTER 1 (0.0%)
STREET 1 (0.0%)

Compare BOSTON SCIENTIFIC CORPORATION vs MPRI →

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Implantable Cardioverter Defibrillator: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (379,353 here).

Similar death-typed counts

Nearest other device types by death-typed report count (10,094 here), distinct from the volume row.

Disclaimer: MAUDE figures for Implantable Cardioverter Defibrillator are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Implantable Cardioverter Defibrillator; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.